bufexamac - CISMeF

Preferred Label : bufexamac;

MeSH definition : A benzeneacetamide with anti-inflammatory, analgesic, and antipyretic action. It is administered topically, orally, or rectally.;

MeSH synonym : p-butoxyphenylacethydroxamic acid; p butoxyphenylacethydroxamic acid;

CISMeF synonym : bufexamac pharmacia brand; acid, p-butoxyphenylacethydroxamic; pharmacia brand of bufexamac; AHP brand of bufexamac; GALENpharma brand of bufexamac; bioglan brand of bufexamac; bufexamac AHP brand; bufexamac GALENpharma brand; bufexamac bioglan brand; bufexamac dermapharm brand; bufexamac pfizer brand; bufexamac ratiopharm brand; bufexamac scheurich brand; bufexamac whitehall brand; dermapharm brand of bufexamac; merck dura brand of bufexamac; pfizer brand of bufexamac; pierre fabre brand of bufexamac; ratiopharm brand of bufexamac; sanofi synthelabo brand of bufexamac; scheurich brand of bufexamac; whitehall brand of bufexamac;

MeSH hyponym : jomax; bufederm; bufexamac-ratiopharm; malipuran; droxaryl; windol; bufal; duradermal; allergipuran; Bufexamac ratiopharm; Bufexamacratiopharm; Paraderm; Parfenac;

MeSH CAS label : benzeneacetamide, 4-butoxy-N-hydroxy-;

MeSH Related Number : 2438-72-4 (Bufexamac);

Registry Number MeSH : 2438-72-4;

Wikipedia link : https://en.wikipedia.org/wiki/Bufexamac;

Codes EINECS : 219-451-1;

Is substance : O;

UNII : 4T3C38J78L;

InChIKey : MXJWRABVEGLYDG-UHFFFAOYSA-N;

Details

Origin ID

D002019;

UMLS CUI

C0006351;

ATC code(s)
- bufexamac [ATC Code]
- bufexamac [ATC Code]
Allowable qualifiers
- administration and dosage [MeSH Qualifier]
- adverse effects [MeSH Qualifier]
- agonists [MeSH Qualifier]
- analogs and derivatives [MeSH Qualifier]
- analysis [MeSH Qualifier]
- antagonists and inhibitors [MeSH Qualifier]
- blood [MeSH Qualifier]
- cerebrospinal fluid [MeSH Qualifier]
- chemical synthesis [MeSH Qualifier]
- chemistry [MeSH Qualifier]
- classification [MeSH Qualifier]
- contraindications [MeSH Qualifier]
- economics [MeSH Qualifier]
- history [MeSH Qualifier]
- immunology [MeSH Qualifier]
- isolation and purification [MeSH Qualifier]
- metabolism [MeSH Qualifier]
- pharmacokinetics [MeSH Qualifier]
- pharmacology [MeSH Qualifier]
- poisoning [MeSH Qualifier]
- radiation effects [MeSH Qualifier]
- standards [MeSH Qualifier]
- supply and distribution [MeSH Qualifier]
- therapeutic use [MeSH Qualifier]
- toxicity [MeSH Qualifier]
- urine [MeSH Qualifier]
CISMeF manual mappings
- bufexamac [Substance BNPC]
Currated CISMeF NLP mapping
- Bufexamac [NCIt concept]
- Bufexamac (substance) [SNOMED CT concept]
Pharmacological action(s)
- anti-inflammatory agents, non-steroidal [MeSH Descriptor]
Record concept(s)
- allergipuran [MeSH concept]
- bufal [MeSH concept]
- bufederm [MeSH concept]
- bufexamac [MeSH concept]
- bufexamac-ratiopharm [MeSH concept]
- droxaryl [MeSH concept]
- duradermal [MeSH concept]
- jomax [MeSH concept]
- malipuran [MeSH concept]
- windol [MeSH concept]
See also inter- (CISMeF)
- Product containing bufexamac (medicinal product) [SNOMED CT concept]
Semantic type(s)
- Organic Chemical [UMLS semantic type]
- Pharmacologic Substance [UMLS semantic type]
UMLS correspondences (same concept)
- Bufexamac [NCIt concept]
- Bufexamac (substance) [SNOMED CT concept]
- Product containing bufexamac (medicinal product) [SNOMED CT concept]
- bufexamac [ATC Code]
- bufexamac [ATC Code]
- bufexamac [Substance BNPC]
Validated automatic mappings to BTNT
- bufexamac [ATC Code]
- bufexamac [ATC Code]

Keyword's position in hierarchy(ies) :

You can consult :

recommendations
documents concerning education
documents for patients